You are here

  • Home
  • Archive
  • Volume 70, Issue 12
  • Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma

Article metrics

Article menu
Download PDFPDF
Stomach
Original research
Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma

 

Online download statistics by month:

Online download statistics by month: January 2021 to August 2024

AbstractFullPdf
Jan 20217196028
Feb 202115487754
Mar 20216105536
Apr 20213152241
May 20211171920
Jun 2021262514
Jul 2021242113
Aug 2021181510
Sep 2021211911
Oct 20211982012
Nov 202110789974
Dec 20217006738
Jan 20223064823
Feb 20225073814
Mar 20224512526
Apr 20223562013
May 2022286135
Jun 2022311299
Jul 2022429268
Aug 20222792512
Sep 20224623214
Oct 2022369308
Nov 20222824612
Dec 202218993
Jan 2023120126
Feb 2023336185
Mar 2023224154
Apr 20231441912
May 2023214165
Jun 202310260
Jul 202313092
Aug 202313333
Sep 2023260177
Oct 2023578174
Nov 2023877116
Dec 202325065
Jan 202413168
Feb 202415564
Mar 20242142713
Apr 202412897
May 202412664
Jun 202418745
Jul 202413176
Aug 20249153
Total141321059607